Literature DB >> 20075586

Takayasu's arteritis in a patient with Crohn's disease: an unexpected association during infliximab therapy.

Nagaaki Katoh1, Mayu Kubota, Yasuhiro Shimojima, Wataru Ishii, Masayuki Matsuda, Taiji Akamatsu, Shu-ichi Ikeda.   

Abstract

We report a 20-year-old woman with Crohn's disease (CD) who developed anterior neck pain while being treated with the anti-tumor necrosis factor (TNF)-alpha monoclonal antibody, infliximab. She showed no symptoms suggestive of active CD except for tenderness along the left common carotid artery with marked increases in serum TNF-alpha and inflammatory reactions. Based on thickened walls of large vessels with enhancement effects on computed tomography, she was diagnosed as having associated Takayasu's arteritis (TA), which was successfully treated with corticosteroid. Even if CD is controlled by infliximab, other autoimmune disorders, such as TA, may develop as a complication.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075586     DOI: 10.2169/internalmedicine.49.2491

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  9 in total

Review 1.  Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature.

Authors:  Alice Sy; Nader Khalidi; Natasha Dehghan; Lillian Barra; Simon Carette; David Cuthbertson; Gary S Hoffman; Curry L Koening; Carol A Langford; Carol McAlear; Larry Moreland; Paul A Monach; Philip Seo; Ulrich Specks; Antoine Sreih; Steven R Ytterberg; Gert Van Assche; Peter A Merkel; Christian Pagnoux
Journal:  Semin Arthritis Rheum       Date:  2015-07-26       Impact factor: 5.532

2.  Crohn's disease and Takayasu's arteritis: an uncommon association.

Authors:  Andrea Taddio; Massimo Maschio; Stefano Martelossi; Egidio Barbi; Alessandro Ventura
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

3.  Clinically silent Crohn's disease in a patient with Takayasu's arteritis unresponsive to conventional therapies.

Authors:  Neslihan Yilmaz; Meryem Can; Fatma Alibaz-Oner; Haner Direskeneli
Journal:  Rheumatol Int       Date:  2012-11-10       Impact factor: 2.631

4.  Effect of infliximab on inflammatory bowel disease with Takayasu arteritis: case series and review of the literature.

Authors:  Naoki Minami; Hiroshi Nakase; Takuya Yoshino; Satoshi Yamada; Takahiko Toyonaga; Yusuke Honzawa; Minoru Matsuura; Tsutomu Chiba
Journal:  Clin J Gastroenterol       Date:  2013-05-10

5.  Takayasu's arteritis occurring under TNF-α blockers: a new paradoxical effect?

Authors:  Leila Souabni; Kaouther Ben Abdelghani; Saoussen Jradi; Leith Zakraoui
Journal:  BMJ Case Rep       Date:  2014-11-24

6.  Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study.

Authors:  Priscille Couture; Thibaud Chazal; Charlotte Rosso; Julien Haroche; Anne Léger; Baptiste Hervier; Sandrine Deltour; Zahir Amoura; Fleur Cohen Aubart
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

7.  Biologic agents in systemic vasculitis.

Authors:  Charles F Henderson; Philip Seo
Journal:  Int J Clin Rheumtol       Date:  2011

Review 8.  Takayasu arteritis in an adolescent with Crohn's disease.

Authors:  Lampros Fotis; Afroditi Kourti; Spyridon Prountzos; Efthymia Alexopoulou; Vasiliki Papaevangelou; Smaragdi Fessatou
Journal:  Rheumatol Int       Date:  2021-04-27       Impact factor: 2.631

Review 9.  Vasculitis induced by biological agents used in rheumatology practice: A systematic review.

Authors:  Camila da Silva Cendon Duran; Adriane Souza da Paz; Mittermayer Barreto Santiago
Journal:  Arch Rheumatol       Date:  2021-12-24       Impact factor: 1.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.